SAENGER BRADLEY (CIK 1668150) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Buy TNXP (701 shares), Sell TNXP (0 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | Buy | 701 | $9,407 |
| 2025-02-27 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | Sell | 0 | $0 |
Source: SEC Form 4 filings · as of 2026-02-17